Healthcare Roundup – White House releases plan, Illumina to pay up to $34M to extend offer for Pacific Bio Dec 18, 2019 Life Science
Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody Dec 18, 2019 Life Science
Healthcare Roundup – Merck adds to aquaculture portfolio, CytoDyn out-licenses U.S. rights to leronlimab for HIV Dec 17, 2019 Life Science
Cellestia Biotech AG successfully closes Series B financing round, raising a total of CHF 20 million Dec 17, 2019 Life Science
TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure Dec 17, 2019 Life Science
Healthcare Roundup – U.S. approves Roche-Spark merger, Ad Com Tuesday for AstraZeneca’s Lynparza for maintenance of pancreatic cancer Dec 16, 2019 Life Science
Healthcare Roundup – Eagle Pharma on go to launch Alimta alternative，FDA clears Boston Scientific single-use duodenoscope Dec 13, 2019 Life Science
United Imaging’s Artificial Intelligence Subsidiary Wins in Facebook AI Research & NYU School of Medicine Global Competition Dec 13, 2019 Life Science
Healthcare Roundup – House passes drug pricing bill, Roche and Fortelinea to co-market software solutions Dec 12, 2019 Life Science
CStone completes registration filing for the Phase I trial of its tumor immune microenvironment modulator CS3005 to enable study initiation in Australia Dec 12, 2019 Life Science
Zhejiang Medicine and Ambrx Present Positive Top Line Data from a Phase 1a/1b Clinical Trial of ARX788 in Metastatic HER2 Positive Breast Cancer Dec 12, 2019 Life Science
Healthcare Roundup – Assembly Biosciences readies equity offering, Gilead files U.S. application Dec 11, 2019 Life Science
China’s Tianhui Teams With Israel’s Oramed to Make World’s First Insulin Pills in China Dec 11, 2019 Life Science
CStone announces enrollment target reached in the global Phase III VOYAGER trial of avapritinib in Chinese patients with third-line GIST Dec 10, 2019 Life Science
Healthcare Roundup – Momenta Pharma launches $200M stock offering, Sanofi and Regeneron to restructure Dec 10, 2019 Life Science
